[In vitro susceptibility to a new antimicrobial agent (imipenem) of pathogens isolated from inpatients at various centers].
Imipenem is a beta lactam antibiotic, a highly potent new carbapenem with broad antibacterial spectrum. To test the "in vitro" efficacy of this antimicrobial agent in pathogens more frequent in several Medical Centers in Brazil, susceptibility testing with 10 mcg imipenem disks and, or corresponding MIC were carried out with 1231 recent isolates of 41 different bacterial species, obtained mainly from hospitalized patients in 5 different medical centers of the cities of S. Paulo, Rio de Janeiro and Salvador. Our preliminary results with this antibiotic, in final phases of clinical and laboratorial experimentation in this country, are very promissing with, 96.79% of susceptibility of test isolates to 10 mcg imipenem disks and corresponding MIC correlation of up to 4 micrograms/ml. (92.31%). Of the 9 bacterial species more frequently isolated totaling 1108 (82%) of the 1230 test isolates, disk susceptibility was 99% (E. coli), 93% (Pseudomonas aeruginosas), 87% (Staphylococcus aureus), 100% (Klebsiella pneumoniae), 98% (Klebsiella sp), 97% (Proteus mirabiles), 94% (Enterobacter sp), 100% (Streptococcus faecalis) with good MIC correlation (up to 8 mcg/ml) and 100% for the anaerobic species Bacteroides sp (MIC up to 4 micrograms/ml). "In vitro" efficacy to hospital pathogens with high frequency of resistance to most antibiotics as Pseudomonas aeruginosa and to anaerobes notably Bacteroides sp is emphasized.
de Godoy
C V
CV
Mendes
C M
CM
Mimiça
I
I
de Oliveira
M
M
Suassuna
I
I
de Uzeda
M
M
D001419:Bacteria / Q000187:drug effects*; D003428:Cross Infection / Q000382:microbiology*; D006801:Humans; D015378:Imipenem / Q000494:pharmacology*; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests
D015378:Imipenem
Estudo da suscetibilidade "in vitro" a um novo antimicrobiano (imipenem) de patógenos isolados de pacientes hospitalares em vários centros.